CHEMED CORP
NYSE: CHE·Cincinnati, Ohio·CIK 0000019584
- Price
- $549.45
- Base IV
- $441.27
Valuation snapshot
At $549.45, the price sits between our base case ($441.27) and bull case ($642.36).
Values per share, from an .
- No growth
- …
- Loading earnings power
- Base case
- $441.27
- 80% of the price · range $277.03–$642.36
- Price vs base case
- 25% above
- $549.45 against $441.27
- Base case · our researched forecast, 2026-10-31See the research ↗
- Price vs base · derived: price − base caseWhat the price expects ↗
- Price · StockValuer price feed, 2026-11-16 closeno link today
Whisker on the base case runs bear $277.03 to bull $642.36. Values per share.
Price against each value
- Bear case
- $277.03
- Price 98% above
- No growth
- …
- —
- Base case
- $441.27
- Price 25% above
What does Chemed do?
Chemed Corporation provides hospice and palliative care services to patients and plumbing, drain cleaning, and water restoration services to residential and commercial customers.
It brought in $2.7B of sales in the 12 months to Sep 2026.
Led by Kevin J. McNamara, President and Chief Executive Officer since 2001. Chemed Corporation Form 10-K for the Fiscal Year Ended December 31, 2024
- Industry
- Healthcare
- Based in
- Cincinnati, Ohio
- Trades on
- NYSE as CHE
Here is where each dollar a customer pays ends up. Out of every $1 of sales in the 12 months to Sep 2026, about 11¢ was left as profit after every cost, interest and tax. The biggest cost is making what it sells, 66¢ of every dollar.
- Making what it sells66¢
- Sales, marketing and admin17¢
- Everything else it takes to operate3¢
- Tax4¢
- Left as profit11¢
Who pays Chemed, and for what?
Chemed Corporation operates two distinct service businesses: VITAS Healthcare and Roto-Rooter. VITAS delivers hospice and palliative care to patients with terminal illnesses, while Roto-Rooter provides plumbing, drain cleaning, water restoration, and excavation services to homes and commercial facilities.
VITAS is primarily paid by the U.S. government through Medicare and Medicaid, while Roto-Rooter is paid directly by residential homeowners and commercial businesses.
VITAS Healthcare
64%Provides specialized hospice and palliative care through interdisciplinary teams of nurses, doctors, social workers, and counselors.
Roto-Rooter
36%Offers plumbing, pipe and drain cleaning, water cleanup, and excavation services through company-owned branches and franchises.
A Roto-Rooter technician performing drain cleaning using motorized auger equipment.Guynamedpaul, CC BY-SA 3.0, via Wikimedia Commons
Where its work physically happens, beyond headquarters:
- VITAS Healthcare Corporate Office — Miramar, United States. This south Florida headquarters of Chemed's VITAS hospice segment houses HR, finance, marketing, IT and payroll support for a network of 182 facilities and 28 inpatient units in 17 states and D.C., and Chemed has flagged Florida as a substantial source of VITAS revenue.
- Roto-Rooter West Des Moines Manufacturing and Distribution Center — West Des Moines, United States. This is the only manufacturing and distribution site Chemed names in its 10-K, and it builds the sewer and drain cleaning machines, cables, cutting blades, fittings and spare parts that equip Roto-Rooter's service network of 356 office and service facilities in 34 states.
How is the business doing?
Sales grew from $2.1B in 2020 to $2.5B in 2025, about 4% a year.
Running the business leaves about 14¢ of each sales dollar as operating profit, down from 19¢ in 2020.
After paying for its upkeep and new investment, it had $295.5M of cash to spare in the 12 months to Sep 2026.
What does management say it's aiming for?
Chemed exists to acquire, operate, and divest diverse operating companies to generate long-term value for its stockholders.
“purchases, operates and divests subsidiaries engaged in diverse business activities for the purposes of maximizing shareholder value”
Who is responsible for the plan?
- Kevin J. McNamaraPresident and Chief Executive Officer
Kevin J. McNamara oversees all operations, executive management, capital allocation, and corporate strategy across Chemed Corporation and its operating subsidiaries. Chemed Corporation operates as a holding company generating revenue through hospice care services via VITAS Healthcare and plumbing, drain cleaning, and water restoration services via Roto-Rooter.
- Spencer S. LeeExecutive Vice President; Chairman and Chief Executive Officer of Roto-Rooter
Spencer S. Lee oversees the operational management, service operations, and business strategy of Chemed's Roto-Rooter subsidiary. Roto-Rooter generates revenue by delivering residential and commercial plumbing, drain cleaning, pipe repair, and water cleanup and restoration services across North America.
Roles checked November 14, 2026.
What management says it is working on now:
Clinical Staff Recruitment and Retention
VITAS focuses on recruiting and retaining qualified nurses and aides to meet expanding patient demand and reduce dependence on costly contract staff.
Chemed Corp 2025 Form 10-KMedicare Regulatory and Cap Compliance
Management manages patient acuity and lengths of stay to maintain regulatory compliance and stay within annual Medicare aggregate reimbursement caps.
Chemed Corp 2025 Form 10-KRoto-Rooter Customer Acquisition and Tech Hiring
Roto-Rooter is focused on attracting licensed plumbers and managing digital customer acquisition channels to maintain job volumes and market share.
Chemed Corp 2025 Form 10-KCybersecurity and Data Protection
Following a cybersecurity attack, the company is actively upgrading security safeguards to protect sensitive patient healthcare records and customer data.
Chemed Corp 2025 Form 10-K
- Adjusted Diluted Earnings Per Share, Full-Year 2026
- $25.00 to $25.75 (or slightly above)
- Chemed Reports Third-Quarter 2026 Results and Updates Full-Year Guidance
What's changing right now?
Growth is slowing. In Q3 2026 it sold 11% more than a year earlier. The year before, quarters averaged 31%.
Its operating margin is wider than a year ago: 14¢ per sales dollar, against 12¢.
Since Oct 2026 the share price has risen 1%, from $541.92 to $549.45.
Coming up
Late 2027
Expiration of Statutory 2% Medicare Reimbursement Cut
The federal 2% Medicare sequestration reimbursement reduction is scheduled under current legislation to expire after federal fiscal year 2027.
Chemed Corp 2025 Form 10-KLate February 2027
Full-Year 2026 Earnings Release and 2027 Guidance
Chemed reports audited full-year 2026 financial performance and issues initial financial targets and operational outlook for fiscal 2027.
Chemed Investor Relations CalendarMay 2027
Annual Meeting of Stockholders
Chemed convenes its annual stockholder meeting to conduct executive elections, vote on governance proposals, and review corporate strategy.
Chemed Corp 2025 Form 10-K
What could go wrong?
No business is a sure thing. These are the risks we found, starting with the ones the company itself names. Where a risk would change part of the valuation, it says which.
Heavy Dependence on Medicare and Medicaid Reimbursements
Over 95% of VITAS revenue comes from government healthcare programs. Rate cuts, billing disputes, or payment freezes would directly hurt revenue and profits.
From the company's own filingsWould hit how fast sales growChemed Corp 2025 Form 10-K
Medicare Per-Admission and Inpatient Reimbursement Caps
Medicare limits average payments per admission and inpatient days. If payments exceed these annual caps, VITAS must refund excess funds to the government.
From the company's own filingsWould hit how much of each sale it keepsChemed Corp 2025 Form 10-K
Shortages of Qualified Healthcare and Plumbing Labor
Shortages of licensed nurses, home health aides, and plumbers drive up wage costs and rely on expensive contract labor, compressing profit margins.
From the company's own filingsWould hit how much of each sale it keepsChemed Corp 2025 Form 10-K
Geographic Concentration and Extreme Weather in Florida
A substantial portion of VITAS operations and headquarters are located in Florida, creating significant vulnerability to operational disruptions from hurricanes.
From the company's own filingsWould hit how fast sales growChemed Corp 2025 Form 10-K
Cybersecurity Breaches and Sensitive Data Exposure
A cyberattack in 2025 accessed protected health data. Further breaches could lead to substantial legal penalties, remediation costs, and operational downtime.
From the company's own filingsWould hit how much of each sale it keepsChemed Corp 2025 Form 10-K
Intense Local and Private Equity Competition in Plumbing
Roto-Rooter faces intense competition from local service firms and private equity-backed home service platforms, increasing customer acquisition costs.
From the company's own filingsWould hit how fast sales growChemed Corp 2025 Form 10-K
Roto-Rooter same-store branch revenue grew at a more modest 5.5% pace in Q3 2026, reflecting normalized demand for commercial and residential emergency plumbing.
From our researchWould hit how fast sales growChemed Reports Third-Quarter 2026 Results
Is it a good business?
From 2016 to 2022 it earned between 14% and 34% on the capital invested in it, a median of 26%. Its cost of capital in the latest valuation is 7.7%; returns were above it in every one of the 6 years.
From 2016 to 2025 it earned between 18% and 43% on its shareholders' equity, a median of 29%.
Over 10 years its operating margin ranged from 7¢ to 29¢ per sales dollar, a median of 16¢. Gross margin ran from 14¢ to 34¢.
It bought back shares: the count fell 8.8% in a year, so each remaining share owns a slightly bigger slice.
It owes $187.6M more than it holds in cash, about 0.5 years of operating profit.
What might it be worth?
The Valuation snapshot at the top of this page shows the answer. This is how we got there. A share is a slice of the business, so what a share is worth depends on what the business can earn for its owners from here on. We estimate that three ways, from cautious to hopeful, and call the result .
Today a share costs $549.45. Our put its value between $277.03 and $642.36, with $441.27 in the middle. Underneath sit two simpler checks: what it would cost to rebuild the business, its , and what today's profit is worth with no growth at all, its .
Bear case, $277.03
This scenario assumes that government hospice reimbursement rules tighten and rising technician and advertising costs slow overall business expansion down from its recent ten percent pace to modest low single digits.
Base case, $441.27
This scenario assumes that steady patient growth at VITAS and routine emergency plumbing demand keep total sales expanding around five to seven percent per year while profitability holds steady near recent averages.
Bull case, $642.36
This scenario assumes that rapid hospice patient admissions and higher commercial plumbing market share propel revenue growth toward ten percent while strong cost discipline lifts overall profitability above recent highs.
Another way in: instead of asking what the business is worth, ask what today's price assumes it will do.
Why the gap?
The price expects more than we do.Price above value: 25%
For Chemed to be worth today's $549.45, sales would need to grow about 10.5% a year. We assume 5.5%. Over the last 5 years, sales grew 12.5% a year.
Or, if sales grow 5.5% as we assume, the price works with a profit margin of 17.9% (we assume 14.5%).
Keep in mind: this is one way to read the price. Investors might be expecting other things, like higher profits or lower risk.
Do you think sales can grow 10.5% a year?
Try your own numbersWe're moderately sure of this range: it scores 66 out of 100 on our checks. The weakest point is terminal-value dependency.
Test the assumptions
Our base value of $441.27 rests on three assumptions. Change any of them to see how the value per share responds.
- Revenue growth, 5-year average5.5%
- Operating margin14.5%
- Long-term growth rate2.8%
This is an educational explanation built from public filings and our own research, not investment advice. It does not tell you whether to buy or sell anything.
Base estimate
$441.27 -19.7%

